Eurofins Genomics LLC — Federal Contractor Profile
EUROFINS GENOMICS LLC: Niche Biotechnology Contractor with Limited Federal Presence
Contractor Overview
Total Contract Value: $19,391 ($19.4K)
Total Awards: 2
Company Profile
EUROFINS GENOMICS LLC is a specialized biotechnology company that provides genomic services and solutions to the federal government. The company's core capabilities include DNA sequencing, genomics research, and bioinformatics. With a total government contract value of $19,390.92 and two contracts, EUROFINS GENOMICS LLC has a modest presence in federal contracting. The company has not won any recent contracts, indicating a lack of new business activity. The nature of their contracts suggests a focus on niche biotechnology services, but the limited number of contracts and the absence of specific agency clients make it difficult to assess their dependency patterns. EUROFINS GENOMICS LLC has not demonstrated a competitive edge in winning contracts, as all contracts were awarded through competitive processes. The company's track record is limited, and without significant projects or performance history, it is challenging to gauge their strategic direction. EUROFINS GENOMICS LLC's business strategy appears to be centered on niche biotechnology services, which may limit their market reach compared to larger, more diversified contractors in the sector.
Specializations
- DNA sequencing
- genomics research
- bioinformatics
- molecular biology
- epigenetics
- transcriptomics
- metagenomics
- epigenetic analysis
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: diversified
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 100%
Competitive Position
EUROFINS GENOMICS LLC operates in a niche market within the biotechnology sector, focusing on specialized genomic services. While the company has not demonstrated a competitive edge in winning contracts, their focus on niche biotechnology services suggests they may be a preferred provider for agencies requiring specialized expertise. However, their limited presence in federal contracting and lack of significant projects or performance history indicate that they are not a dominant player in the market. Their reliance on competitive processes for contract awards suggests they face competition from other specialized biotechnology firms.
Value to Taxpayers
EUROFINS GENOMICS LLC provides specialized genomic services, which are critical for research and development in biotechnology. The company's focus on niche services suggests they may offer high-quality, specialized solutions. However, the limited number of contracts and the absence of significant projects or performance history make it difficult to assess their value to taxpayers. The average contract size of $9,695.46 is relatively small, which may indicate that the company is not a major player in federal contracting. Given the specialized nature of their services, the company may offer good value for the specific needs of federal agencies, but a more comprehensive assessment would be needed to confirm this.
Agency Relationships
EUROFINS GENOMICS LLC has not demonstrated a strong dependency on any specific federal agency, as there are no specific agency clients listed. This diversified client base may reduce dependency risks, but the lack of significant projects or performance history makes it difficult to assess the strength of their relationships with federal agencies. The absence of notable projects or performance history also suggests that the company may not have a strong track record of delivering high-quality services to federal agencies.
Red Flags
- Lack of recent contracts: EUROFINS GENOMICS LLC has not won any recent contracts, indicating a lack of new business activity.
- Limited contract value: The average contract size of $9,695.46 is relatively small, which may indicate that the company is not a major player in federal contracting.
- No significant projects or performance history: The company's track record is limited, and without significant projects or performance history, it is challenging to gauge their strategic direction.
Green Flags
- Niche specialization: EUROFINS GENOMICS LLC focuses on specialized genomic services, which may make them a preferred provider for agencies requiring specialized expertise.
- Competitive contract awards: All contracts were awarded through competitive processes, indicating that the company is not reliant on sole-source awards.
- Diversified client base: The company has not demonstrated a strong dependency on any specific federal agency, which may reduce dependency risks.
Key Contracts
EUROFINS GENOMICS LLC has two contracts with a total value of $19,390.92. While the company has not won any recent contracts, the nature of their contracts suggests a focus on niche biotechnology services. The limited number of contracts and the absence of specific agency clients make it difficult to assess their dependency patterns. The company's track record is limited, and without significant projects or performance history, it is challenging to gauge their strategic direction. The contracts indicate that EUROFINS GENOMICS LLC provides specialized genomic services, which are critical for research and development in biotechnology. However, the limited number of contracts and the absence of significant projects or performance history make it difficult to assess the company's capabilities, performance, and strategic direction.
Frequently Asked Questions
What does EUROFINS GENOMICS LLC do for the federal government?
EUROFINS GENOMICS LLC provides specialized genomic services and solutions to the federal government, including DNA sequencing, genomics research, and bioinformatics. The company's core capabilities include molecular biology, epigenetics, transcriptomics, and metagenomics. Their services are critical for research and development in biotechnology, and they focus on niche biotechnology services to meet the specific needs of federal agencies.
How much taxpayer money does EUROFINS GENOMICS LLC receive?
EUROFINS GENOMICS LLC has received a total of $19,390.92 in government contracts. The company has two contracts, with an average contract size of $9,695.46. While the total contract value is modest, the company has not won any recent contracts, indicating a lack of new business activity.
Is EUROFINS GENOMICS LLC good value for taxpayer money?
EUROFINS GENOMICS LLC provides specialized genomic services, which are critical for research and development in biotechnology. The company's focus on niche services suggests they may offer high-quality, specialized solutions. However, the limited number of contracts and the absence of significant projects or performance history make it difficult to assess their value to taxpayers. The average contract size of $9,695.46 is relatively small, which may indicate that the company is not a major player in federal contracting. Given the specialized nature of their services, the company may offer good value for the specific needs of federal agencies, but a more comprehensive assessment would be needed to confirm this.
How does EUROFINS GENOMICS LLC win its contracts?
EUROFINS GENOMICS LLC has won its contracts through competitive processes. The company has not demonstrated a competitive edge in winning contracts, as all contracts were awarded through competitive processes. This suggests that the company faces competition from other specialized biotechnology firms and may not have a significant advantage in the market.
What agencies use EUROFINS GENOMICS LLC most?
EUROFINS GENOMICS LLC has not demonstrated a strong dependency on any specific federal agency, as there are no specific agency clients listed. This diversified client base may reduce dependency risks, but the lack of significant projects or performance history makes it difficult to assess the strength of their relationships with federal agencies. The absence of notable projects or performance history also suggests that the company may not have a strong track record of delivering high-quality services to federal agencies.
What are the risks of relying on EUROFINS GENOMICS LLC?
The risks of relying on EUROFINS GENOMICS LLC include the lack of recent contracts, which indicates a lack of new business activity. The limited contract value and the absence of significant projects or performance history make it difficult to assess the company's capabilities, performance, and strategic direction. The company's focus on niche biotechnology services may limit their market reach compared to larger, more diversified contractors in the sector. Additionally, the absence of specific agency clients and the lack of significant projects or performance history suggest that the company may not have a strong track record of delivering high-quality services to federal agencies.
How does EUROFINS GENOMICS LLC compare to similar contractors?
EUROFINS GENOMICS LLC operates in a niche market within the biotechnology sector, focusing on specialized genomic services. While the company has not demonstrated a competitive edge in winning contracts, their focus on niche biotechnology services suggests they may be a preferred provider for agencies requiring specialized expertise. However, their limited presence in federal contracting and lack of significant projects or performance history indicate that they are not a dominant player in the market. Their reliance on competitive processes for contract awards suggests they face competition from other specialized biotechnology firms. In comparison to larger, more diversified contractors in the sector, EUROFINS GENOMICS LLC may be more specialized but less competitive in terms of market reach and business volume.
Recent Federal Contracts
Eurofins Genomics LLC has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| USDA's Agricultural Research Service awards $9,695 for nutritional testing to... | Department of Agriculture | $9.7K | N/A |